Antibodies 2014, 3(2), 232-241; doi:10.3390/antib3020232
Review

Refolding Technologies for Antibody Fragments

1,* email and 2
Received: 20 January 2014; in revised form: 26 April 2014 / Accepted: 13 May 2014 / Published: 23 May 2014
(This article belongs to the Special Issue Antibody Constructs)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Refolding is one of the production technologies for pharmaceutical grade antibody fragments. Detergents and denaturants are primarily used to solubilize the insoluble proteins. The solubilized and denatured proteins are refolded by reducing the concentration of the denaturants or detergents. Several refolding technologies have been used for antibody fragments, comprising dilution, dialysis, solid phase solvent exchange and size exclusion chromatography, as reviewed here. Aggregation suppressor or folding-assisting agents, including arginine hydrochloride, ionic liquids and detergents or denaturants at low concentrations, are included in the refolding solvent to enhance refolding yield.
Keywords: refolding; dialysis; dilution; C12-L-Glu; antibody; fragments
PDF Full-text Download PDF Full-Text [343 KB, Updated Version, uploaded 26 May 2014 08:43 CEST]
The original version is still available [353 KB, uploaded 23 May 2014 14:25 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Arakawa, T.; Ejima, D. Refolding Technologies for Antibody Fragments. Antibodies 2014, 3, 232-241.

AMA Style

Arakawa T, Ejima D. Refolding Technologies for Antibody Fragments. Antibodies. 2014; 3(2):232-241.

Chicago/Turabian Style

Arakawa, Tsutomu; Ejima, Daisuke. 2014. "Refolding Technologies for Antibody Fragments." Antibodies 3, no. 2: 232-241.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert